Don't want ads? Subscribe or login now.

Gilead Defective Drug FCA Suit Tossed For Second Time

By Bryan Koenig · June 15, 2015, 6:02 PM EDT

Changes to a False Claims Act lawsuit alleging Gilead Sciences Inc. sought Medicare and Medicaid reimbursement for shoddily made drugs were not enough to save it in California federal court Friday,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order on Motion to Dismiss

Case Information

Case Title

United States of America et al -v- Gilead Sciences, Inc. et al

Case Number

3:11-cv-00941

Court

California Northern

Nature of Suit

Other Statutory Actions

Date Filed

March 01, 2011

Recent Articles By Bryan

July 26, 2024
FTC Powers Get A Boost In Philly In Noncompete Ban Saga
July 23, 2024
Philly Judge Won't Block FTC Noncompete Ban
July 19, 2024
FTC Wants To Block Kroger & Albertsons' 'Principal Defense'
July 19, 2024
What The End Of Chevron Means For FTC Rulemaking
July 17, 2024
FTC Cites 3rd Circ. In Defending Noncompete Ban
July 17, 2024
Heart Doctor's Sham Suit Claims Cut From Antitrust Row
July 16, 2024
FTC's In-House Kroger Case Delayed Until After Fed Suit
July 10, 2024
FTC Must Think Hard Before Trying More Rules, Commish Says
June 18, 2024
Meat Plant Workers Seek OK On Latest $4M Wage-Fix Deal
June 04, 2024
DOJ Remains 'Clear Eyed' About No-Poach Prosecutions